Literature DB >> 22881025

Impact of vaccine arrival on the optimal control of a newly emerging infectious disease: A theoretical study.

Bruno Buonomo1, Eleonora Messina.   

Abstract

When a newly emerging human infectious disease spreads through a host population, it may be that public health authorities must begin facing the outbreaks and planning an intervention campaign when not all intervention tools are readily available. In such cases, the problem of finding optimal intervention strategies to minimize both the disease burden and the intervention costs may be addressed by considering multiple intervention regimes. In this paper, we consider the scenario in which authorities may rely initially only on non-pharmaceutical interventions at the beginning of the campaign, knowing that a vaccine will later be available, at an exogenous and known switching time. We use a two-stage optimal control problem over a finite time horizon to analyze the optimal intervention strategies during the whole campaign, and to assess the effects of the new intervention tool on the preceding stage of the campaign. We obtain the optimality systems of two connected optimal control problems, and show the solution profiles through numerical simulations.

Entities:  

Mesh:

Year:  2012        PMID: 22881025     DOI: 10.3934/mbe.2012.9.539

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  2 in total

Review 1.  Lessons from past pandemics: a systematic review of evidence-based, cost-effective interventions to suppress COVID-19.

Authors:  Carl-Etienne Juneau; Tomas Pueyo; Matt Bell; Genevieve Gee; Pablo Collazzo; Louise Potvin
Journal:  Syst Rev       Date:  2022-05-12

2.  Investigation of nonlinear epidemiological models for analyzing and controlling the MERS outbreak in Korea.

Authors:  Inkyung Ahn; Seongman Heo; Seunghyun Ji; Kyung Hyun Kim; Taehwan Kim; Eun Joo Lee; Jooyoung Park; Keehoon Sung
Journal:  J Theor Biol       Date:  2017-10-12       Impact factor: 2.691

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.